NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 11:26AM ET
7.14
Dollar change
-0.10
Percentage change
-1.38
%
Index- P/E- EPS (ttm)-0.43 Insider Own13.64% Shs Outstand16.08M Perf Week-27.61%
Market Cap124.71M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.07M Perf Month-23.25%
Enterprise Value153.39M PEG- EPS next Q-0.13 Inst Own7.74% Short Float4.62% Perf Quarter84.15%
Income-6.96M P/S6.91 EPS this Y- Inst Trans48.27% Short Ratio3.06 Perf Half Y65.01%
Sales18.05M P/B28.98 EPS next Y- ROA-14.42% Short Interest0.70M Perf YTD53.66%
Book/sh0.25 P/C11.54 EPS next 5Y- ROE-41.79% 52W High10.95 -34.74% Perf Year226.26%
Cash/sh0.62 P/FCF159.89 EPS past 3/5Y55.49% 39.27% ROIC-19.77% 52W Low1.29 453.88% Perf 3Y147.23%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-32.09% -18.61% Gross Margin21.20% Volatility12.86% 12.13% Perf 5Y122.82%
Dividend TTM- EV/Sales8.50 EPS Y/Y TTM86.71% Oper. Margin-43.92% ATR (14)1.01 Perf 10Y-25.18%
Dividend Ex-DateApr 01, 2022 Quick Ratio0.83 Sales Y/Y TTM-36.30% Profit Margin-38.58% RSI (14)39.25 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.83 EPS Q/Q45.87% SMA20-22.74% Beta2.21 Target Price24.00
Payout- Debt/Eq0.56 Sales Q/Q- SMA50-7.82% Rel Volume4.83 Prev Close7.24
Employees10 LT Debt/Eq0.37 EarningsMay 13 BMO SMA20046.83% Avg Volume228.02K Price7.14
IPONov 07, 1991 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume366,030 Change-1.38%
Jun-30-25 08:00AM
Jun-11-25 12:00PM
May-27-25 09:00AM
08:30AM
May-21-25 04:18PM
09:18AM Loading…
May-14-25 09:18AM
May-13-25 08:00AM
May-09-25 05:00PM
Apr-10-25 08:00AM
Mar-31-25 10:30AM
Mar-28-25 04:10PM
Mar-26-25 09:00AM
Feb-26-25 02:00PM
Feb-20-25 08:30AM
Feb-18-25 08:30AM
03:00PM Loading…
Feb-13-25 03:00PM
Feb-03-25 07:30AM
Jan-31-25 03:51PM
Jan-15-25 07:00AM
Jan-10-25 08:30AM
Jan-09-25 11:30AM
Dec-18-24 04:00PM
Nov-27-24 07:00AM
Nov-12-24 05:23PM
Nov-06-24 08:30AM
Oct-30-24 10:30AM
Oct-23-24 05:00PM
Oct-09-24 08:30AM
Oct-02-24 08:30AM
Sep-10-24 11:00AM
08:00AM Loading…
Sep-09-24 08:00AM
Aug-26-24 08:45AM
Aug-23-24 11:00AM
Aug-19-24 06:30PM
Aug-13-24 08:30AM
Jul-25-24 08:30AM
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Virland AChief Financial OfficerDec 06 '24Buy3.003,0009,0003,000Dec 10 02:54 PM
Tassiopoulos PeterChief Executive OfficerSep 09 '24Buy2.065,00010,278420,000Sep 11 11:57 AM